3,4-dihydroxyphenylacetic acid has been researched along with phaclofen in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Cano, J; Machado, A; Santiago, M | 1 |
Przekop, F; Tomaszewska-Zaremba, D | 1 |
3 other study(ies) available for 3,4-dihydroxyphenylacetic acid and phaclofen
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Regulation of the prefrontal cortical dopamine release by GABAA and GABAB receptor agonists and antagonists.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Baclofen; Dopamine; GABA-A Receptor Antagonists; GABA-B Receptor Antagonists; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Microdialysis; Muscimol; Nomifensine; Picrotoxin; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, GABA-A; Receptors, GABA-B | 1993 |
Effects of GABAB receptor modulation on gonadotropin-releasing hormone and beta-endorphin release, and on catecholaminergic activity in the ventromedial hypothalamus-infundibular nucleus region of anoestrous ewes.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Baclofen; beta-Endorphin; Dopamine; Estrous Cycle; Extracellular Space; Female; GABA Agonists; GABA Antagonists; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Methoxyhydroxyphenylglycol; Norepinephrine; Pituitary Gland, Posterior; Receptors, GABA-B; Sheep; Ventromedial Hypothalamic Nucleus | 2005 |